Global Journal of Science Frontier Research, G: Bio-Tech & Genetics, Volume 22 Issue 2
12. Brown DG, Wilkerson EC, Love WE (March 2015). "A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons". Journal of the American Academy of Dermatology .72(3): 524–534. 13. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. (November 2012). "2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association". European Heart Journal. 33 (21): 2719–2747. 14. Shoeb M, Fang MC (April 2013). "Assessing bleeding risk in patients taking anticoagulants". Journal of Thrombosis and Thrombolysis . 35 (3): 312–319. 15. Elliott MJ, Zimmerman D, Holden RM (September 2007). "Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates". American Journal of Kidney Diseases . 50 (3): 433– 440. 16. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE (July 2011). "A new risk scheme to predict warfarin- associated hemorrhage: The ATRIA (Anticoagula- tion and Risk Factors in Atrial Fibrillation) Study". Journal of the American College of Cardiology . 58 (4): 395–401 17. Zhu Y, Shennan M, Reynolds KK, Johnson NA, Herrnberger MR, Valdes R Jr, et al. Estimation of warfarin maintenance dose based on VKORC1 (−1639 G>A) and CYP2C9 genotypes. ClinChem May 17, 2007 18. Caldwell MD, Berg RL, Zhang KQ, Glurich I, Schmelzer JR, Yale SH, et al. Evaluation of genetic factors for warfarin dose prediction 19. Kealey C, Chen Z, Christie J, Thorn CF, Whitehead AS, Price M, et al. Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity. Modulation of Warfarin Sodium into Warfarin Potassium for Patients with Hypertension © 2022 Global Journals 1 Year 2022 14 Global Journal of Science Frontier Research Volume XXII Issue ersion I VII ( G )
RkJQdWJsaXNoZXIy NTg4NDg=